Sandecka, Viera
Popkova, Tereza
Stork, Martin
Maisnar, Vladimir
Minarik, Jiri
Jungova, Alexandra
Pavlicek, Petr
Stejskal, Lukas
Pospisilova, Lenka
Heindorfer, Adriana
Obernauerova, Jarmila
Gregora, Evzen
Sykora, Michal
Ullrychova, Jana
Wrobel, Marek
Kessler, Petr
Jelinek, Tomas http://orcid.org/0000-0002-5467-9253
Kunovszki, Peter
Bathija, Sacheeta
Gros, Blanca
Wilbertz, Sabine
Cai, Qian
Lam, Annette
Spicka, Ivan http://orcid.org/0000-0002-5451-5283
Funding for this research was provided by:
Janssen Global Services, LLC
Article History
Received: 19 April 2023
Revised: 8 August 2023
Accepted: 23 August 2023
First Online: 27 September 2023
Competing interests
: TP, M Stork, AJ, LS, LP, AH, JO, EG, M Sykora, JU, and MW declare no competing interests. VS: consultancy roles: Amgen, Janssen, Sanofi, and Taketa; financial support (for attending meetings and/or travel): Amgen, Celgene, Janssen, Sanofi, and Takeda; and honoraria: Amgen, Janssen, Sanofi, and Takeda. P Kessler: speaker: Takeda. VM: consultancy roles: Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Sanofi, Takeda, and The Binding Site; advisory board participation: Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Sanofi, and Takeda; financial support (for attending meetings and/or travel): Amgen, Bristol-Myers Squibb, Celgene, Janssen, and Takeda; honoraria: Amgen, Bristol-Myers Squibb, Celgene, Janssen, Sanofi, Takeda, and The Binding Site. JM: consultancy roles: Amgen, Bristol-Myers Squibb, Celgene, Janssen, Sanofi, and Takeda; advisory board participation: Oncopeptides; financial support (for attending meetings and/or travel): Bristol-Myers Squibb, Janssen, and Takeda; and honoraria: Bristol-Myers Squibb, Celgene, Janssen, Sanofi, and Takeda. PP: grants: Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Jansen, Sanofi, and Takeda. TJ: grants: Amgen and Sanofi; and honoraria: Bristol-Myers Squibb, GlaxoSmithKline, Janssen, and Takeda. P Kunovszki, SB, BG, SW, QC, and AL: employees: Janssen. IS: consultancy roles: Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Novartis, PharmaMar, Sanofi, and Takeda; advisory boards participation: Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Novartis, PharmaMar, Sanofi, and Takeda; financial support (for attending meetings and/or travel): Amgen, Bristol-Myers Squibb, Celgene, Janssen, and Takeda; honoraria: Amgen, Bristol-Myers Squibb, Celgene, Janssen, Sanofi, and Takeda; and other financial/nonfinancial interests: Amgen, Bristol-Myers Squibb, Celgene, and Janssen.